Neumora Therapeutics, Inc. insider trading
NMRA$0.50-0.05 (-9.09%)
“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.”
Insider Trading vs Stock Price
Insider Trading vs Stock Price data
Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (-71.9%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.
| Date | Category | Person | Role | Action | Amount | Change in holding |
|---|
Open market purchase
Open market sellNet dollar flow · Buy / Sell balance
PremiumQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Unlock quarterly net flowKey players
- KBKristina Burow18.0395%
- PLPaul L. Berns4.1483%
- RARobert A. Lenz0.1645%
- JPJoshua Pinto0.1117%
- DSDaljit Singh Aurora0.0259%
- MLMichael Lee Milligan0.0112%
- MKMatthew K. Fust0.0107%
- AVARCH Venture Partners XII, LLCNot reported
- AVARCH Venture Partners VIII, LLCNot reported
AI Activity Analysis
PremiumComing soon
Insider activity
Fromto
| Company | Insider / role | Action | ΔOwn | Avg price | Amount | ||
|---|---|---|---|---|---|---|---|
| NMRA | Daljit Singh Aurora | Open market sell$21.9K | -6.9% | $3.56 | $21.9K | Feb 17, 2026 | Feb 19, 2026 |
| NMRA | Joshua Pinto | Open market sell$21.1K | -2.8% | $3.54 | $21.1K | Feb 17, 2026 | Feb 19, 2026 |
| NMRA | Paul L. Berns | Open market sell$34.5K | -0.1% | $3.51 | $34.5K | Feb 17, 2026 | Feb 19, 2026 |
| NMRA | Michael Lee Milligan | Open market sell$5.13K | -6.4% | $3.57 | $5.13K | Feb 17, 2026 | Feb 19, 2026 |
| NMRA | Daljit Singh Aurora | Open market sell$307K | -56.3% | $2.68 | $307K | Nov 11, 2025 | Nov 13, 2025 |
| NMRA | Kristina Burow | Open market purchase$5M | +6.0% | $2.61 | $5M | Oct 27, 2025 | Oct 29, 2025 |
| NMRA | ARCH Venture Partners XII, LLC | Open market purchase$5M | +6.0% | $2.61 | $5M | Oct 27, 2025 | Oct 29, 2025 |
| NMRA | ARCH Venture Partners VIII, LLC | Open market purchase$5M | +6.0% | $2.61 | $5M | Oct 27, 2025 | Oct 29, 2025 |